Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III StudyHans von der Maase, PierFranco Conte, Alexander Knuth et al.|Journal of Clinical Oncology|2000Cited by 2.3k
Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerHans von der Maase, M. Arning, Lisa Sengeløv et al.|Journal of Clinical Oncology|2005Cited by 1.9k
Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory diseaseAlfredo Berruti, Luigi Dogliotti, Alessandra Mosca et al.|Endocrine Related Cancer|2005Cited by 136
Chromogranin A Expression in Patients With Hormone Naïve Prostate Cancer Predicts the Development of Hormone Refractory DiseaseAlfredo Berruti, Luigi Dogliotti, Alessandra Mosca et al.|The Journal of Urology|2007Cited by 89